Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.
Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
ROXANE LABORATORIES, INC., Plaintiff-Appellant
v.
CAMBER PHARMACEUTICALS INC., INVAGEN PHARMACEUTICALS INC., Defendants-Appellees ______________________
2014-1803 ______________________
Appeal from the United States District Court for the District of New Jersey in No. 2:14-cv-04042-SRC-CLW, Judge Stanley R. Chesler. ______________________
JUDGMENT ______________________
KENNETH G. SCHULER, Latham & Watkins LLP, Chi- cago, IL, argued for plaintiff-appellant. Also represented by MARC NATHAN ZUBICK; ALEXANDER ENRICO LONG, San Diego, CA; GREGORY SOBOLSKI, San Francisco, CA; ROBERT J. GAJARSA, Washington, DC.
ROBERT S. SILVER, Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd., Philadelphia, PA, argued for defendants- appellees. Also represented by JAMES J. KOZUCH, SALVATORE GUERRIERO, PEI-RU WEY. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (LOURIE, REYNA, and CHEN, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
March 12, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court
Reference
- Status
- Unpublished